Monopar gets rights to Onxeo's Validive

Onxeo S.A. (Euronext:ONXEO; CSE:ONXEO) granted Monopar Therapeutics Inc. (Northbrook, Ill.) exclusive, worldwide

Read the full 126 word article

User Sign In